-----------------------------------
OMB APPROVAL
-----------------------------------
OMB Number: 3235-0145
Expires: August 31, 1999
Estimated average burden
hours per response...........14.90
-----------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
HI-TECH PHARMACAL CO., INC.
_____________________________________________________________
(Name of Issuer)
COMMON STOCK
_____________________________________________________________
(Title of Class of Securities)
42840B101
_____________________________________________________________
(CUSIP Number)
December 31, 1998
_____________________________________________________________
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
_
|_| Rule 13d-1(b)
|_| Rule 13d-1(c)
|X| Rule 13d-1(d)
-
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 7 pages
<PAGE>
CUSIP No. 42840B101 13G Page 2 of 7 Pages
1. Name of Reporting Persons I.R.S. Identification Nos. of Above Persons
(entities only): Bernard Seltzer
2. Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b) Not applicable
3. SEC Use Only
4. Citizenship or Place of Organization: United States
5. Sole Voting Power
NUMBER OF SHARES 726,332
BENEFICIALLY 6. Shared Voting Power
-0-
OWNED BY EACH
7. Sole Dispositive Power
REPORTING PERSON 726,332
WITH 8. Shared Dispositive Power
-0-
9. Aggregate Amount Beneficially Owned by Each Reporting Person
726,332
10. Check if the Aggregate Amount in Row (9)
Excludes Certain Shares (See Instructions) [ ]
11. Percent of Class Represented by Amount in Row (9)
16.1%
12. Type of Reporting Person (See Instructions) IN
<PAGE>
CUSIP NO. 42840B101 13G Page 3 of 7 Pages
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Amendment No. 1)
Under the Securities Exchange Act of 1934
HI-TECH PHARMACAL CO., INC.
(Name of Issuer)
Item 1(a)
---------
Name of Issuer: Hi-Tech Pharmacal Co., Inc.
Item 1(b)
---------
Address of Issuer' Principal Executive Offices: 369 Bayview Avenue, Amityville,
New York 11701
Item 2(a)
---------
Name of Person Filing: Bernard Seltzer
Item 2(b)
---------
Address of Principal Business Office or, if none, Residence: 369 Bayview Avenue,
Amityville, New York 11701
Item 2(c)
---------
Citizenship: United States
Item 2(d)
---------
Title of Class of Securities: Common Stock
<PAGE>
CUSIP NO. 42840B101 13G Page 4 of 7 Pages
Item 2(e)
---------
CUSIP Number: 42840B101
Item 3
---------
If this statement is filed pursuant to SS240.13d-1(b) or 240.13d-2(b) or
(c), check whether the person is a:
(a) [ ] Broker or dealer registered under Section 15 of the Act
(15 U.S.C. 78o).
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) [ ] Insurance Company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).
(d) [ ] Investment Company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e) [ ] An investment adviser in accordance with SS240.13d-1(b)(1)
(ii)(E).
(f) [ ] An employee benefit plan or endowment fund in accordance
with SS240.13d-1(b)(1)(ii)(F).
(g) [ ] A parent holding company or control person in accordance
with SS240.13d-1(b)(ii)(G).
(h) [ ] A savings association as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813).
(i) [ ] A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment Company Act of 1940
(15 U.S.C. 80a-3).
Not applicable
<PAGE>
CUSIP NO. 42840B101 13G Page 5 of 7 Pages
Item 4
---------
Ownership:
Provide the following information regarding the aggregate number and percentage
of the class of securities of the issuer identified in Item 1.
(a) Amount Beneficially Owned:
726,332
.....................................................................
(b) Percent of Class:
16.1%
.....................................................................
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote................726,332
(ii) Shared power to vote or to direct the vote..................-0-
(iii) Sole power to dispose or to direct the disposition of...726,332
(iv) Shared power to dispose or to direct the disposition of.....-0-
Item 5
---------
Ownership of Five Percent or Less of a Class:
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [ ].
Item 6
---------
Ownership of More than Five Percent on Behalf of Another Person.
Not applicable
Item 7
---------
Identification and Classification of the Subsidiary Which Acquired the Security
Being Reported on By the Parent Holding Company.
Not applicable
<PAGE>
CUSIP NO. 42840B101 13G Page 6 of 7 Pages
Item 8
---------
Identification and Classification of Members of the Group.
Not applicable
Item 9
---------
Notice of Dissolution of Group.
Not applicable
Item 10
---------
Certification.
Not applicable
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated: February 10, 1999
/s/Bernard Seltzer
-------------------
Bernard Seltzer
